Yang, Lujing
Chen, Pengju
Zhang, Li
Wang, Lin
Sun, Tingting
Zhou, Lixin
Li, Zhongwu
Wu, Aiwen
Article History
Received: 23 September 2019
Revised: 27 April 2020
Accepted: 17 June 2020
First Online: 6 July 2020
Ethics approval and consent to participate
: This study was performed in accordance with legal requirements after approval by the Ethics Committee of Peking University Cancer Hospital. Informed consent was obtained from all individual participants included in the study. This study was performed in accordance with the Declaration of Helsinki.
: All data not included in this published article are available upon reasonable request. Supplementary information is available on the British Journal of Cancer’s website.
: The authors declare no competing interests.
: This study was supported by the Beijing Municipal Science and Technology Commission NOVA program (No. 2010 B033), the Beijing Municipal Science and Technology Commission Capital Characteristic Clinical Application Research (No. Z141107002514077), Capital’s Funds for Health Improvement and Research 2018-2-1022 and the National Nature Science Foundation of China (No. 81773214).